Recombinant human growth hormone (r-hGH) overexpressed in Escherichia coli forms inactive and insoluble aggregates as inclusion bodies in the cytoplasm. The efficient solubilization of inclusion bodies is critical for cost-effective production. Contrary to a previous report, in our production system, the solubilization method by alkaline treatment including 2 M urea was ineffective. Hence various buffers containing different concentrations of urea or guanidine hydrochloride (GnHCl) at neutral and alkaline pH were attempted. Efficient solubilization (about 90%) was observed in 100 mM Tris buffer, pH 8.0, with more than 4 M GnHCl, and at pH 12.5 with more than 2 M GnHCl, but not with about 8 M of urea. The r-hGH solubilized at pH 12.5 containing 2 M GnHCl was refolded by simple dilution and purified by DEAE Sepharose anion-exchange chromatography. The biological activity of the resulting r-hGH was comparable with commercially available r-hGH in in vitro cell proliferation assay using the hGHdependent cell line.
Escherichia coli is the most commonly used host for expressing recombinant proteins that do not require posttranslational modifications such as N-linked glycosylation. 1, 2) Strong inducible promoters, such as T7, P R , P L , and tac, are widely used in the overproduction of recombinant proteins, but high-level production of functional proteins, especially those of eukaryotic origin, has often been difficult because overexpression of recombinant proteins in E. coli using such strong promoters is associated with the formation of insoluble protein aggregates in vivo as inclusion bodies. [3] [4] [5] Therefore, solubilization and renaturation of inclusion bodies is a major issue in the efficient production of active proteins. 6, 7) Growth hormone (GH) is a polypeptide hormone secreted by the somatotroph cells in the anterior portion of the pituitary gland of vertebrates. It is involved in the regulation of somatic growth and the maintenance of protein, lipid, carbohydrate, and mineral metabolism. 8) Recombinant human GH (r-hGH) produced in E. coli has been in use as a therapeutic agent against growthretarded GH deficiency (GHD) in children for more than 20 years. Moreover, r-hGH therapy has been approved for other conditions associated with short stature, including Turner syndrome and end-stage renal disease. In adults, it has been also used against adult GHD syndrome and AIDS-associated wasting. 9) Since hGH is a naturally non-glycosylated protein, prokaryotic expression systems have been used in the production of r-hGH, 10) although overexpression of r-hGH in E. coli resulted in the formation of inclusion bodies as with other mammalian proteins. 11) In general, proteins expressed in the form of inclusion bodies are solubilized using high concentrations of chaotropic agents, such as urea, guanidine hydrochloride (GnHCl), and thiocyanate salts, 6, 12) but in most cases, the overall yield of bioactive proteins from the inclusion body solubilized using such high concentrations of chaotropic agents is very low, which accounts for the major cost in the production of recombinant proteins in E. coli.
13)
Improved solubilization and renaturation processes are required to produce them cost-effectively. Recently, it has been found that mild solubilization is the key to high recovery of bioactive protein from inclusion bodies.
14) It is assumed that restoration of a native-like secondary structure under mild solubilization conditions promotes improved recovery of the bioactive protein in comparison with solubilization using high concentrations of chaotropic agents. 15) In order to obtain maximum productivity, it is required to find the mildest conditions of complete solubilization per target protein and production system. Patra et al. have reported that solubilization of r-hGH inclusion bodies at alkaline pH in the presence of 2 M urea solution resulted in about 94% solubility, 14) which is very efficient compared with y To whom correspondence should be addressed. Tel: +81-78-991-4466; Fax: +81-78-991-4465; E-mail: sonoda-h@jcrpharm.co.jp Abbreviations: r-hGH, recombinant human growth hormone; GnHCl, guanidine hydrochloride; FBS, fetal bovine serum; HS, horse serum; IPTG, isopropyl--D-thiogalactopyranoside; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis the conventional alkaline treatment method (around 40%). In our r-hGH production system, however, the solubilization method using alkaline pH with 2 M urea was not effective. Hence the solubility of r-hGH inclusion bodies at different concentrations of urea and GnHCl at neutral and alkaline pH was analyzed, and we found that solubility was improved markedly at more than 2 M GnHCl at pH 12.5 or more than at 4 M at pH 8.0. The method described here might have distinct advantages when solubility at alkaline pH with and without urea is ineffective. We also describe high-level expression of r-hGH using a heat-inducible promoter and a synthetic hGH gene optimized for an E. coli expression system in high cell-density culture with a semi-defined, animal-component-free medium.
Materials and Methods
Bacterial strains, media, and plasmid construction. An hGH gene optimized for the E. coli expression system was designed and synthesized using proprietary software from GENEART GmbH (Regensburg, Germany). The optimization process biases codon usage and GC content for E. coli cells throughout the hGH gene, and aims to remove potentially detrimental cis-acting elements, such as internal RBS sites. The resulting hGH gene was cloned into pRL expression vector (laboratory collection), which includes P R and P L promoters tandemly, a Shine-Dalgarno sequence, multiple cloning sites, an ampicillin resistant gene, and a temperature-sensitive cI857 repressor gene in that order, resulting in pRLhGH. For small-scale culture, E. coli BL21 harboring pRL-hGH was cultured in Luria-Bertani (LB) medium (1% polypepton, 0.5% yeast extract, and 0.5% NaCl, pH 7.0) containing 100 mg/ml of ampicillin at 30 C, and hGH expression was induced by heat shock at 42 C for 4 h. In the bioreactor experiments, synthetic medium TK-25 supplemented with 0.5% yeast extract was used. 16, 17) The TK-25 medium consisted of (g/l) glucose, 20; (NH 4 ) 6 Fermentation. Fermentation was carried out in a 3 liters BMS-03PI laboratory fermenter (Able, Tokyo). The pH was automatically maintained at pH 7.0 with 28% NH 4 OH, and the temperature was maintained at 32 C. To avoid O 2 insufficiency, dissolved O 2 was maintained at above 30% of air saturation by increasing the agitation speed from 600 to 1,000 rpm, followed by adding an air and pure O 2 mixture at 2 l/min. Recombinant gene expression was induced by a temperature shift to 42 C for 5 h. Glucose feeding was started at 6.5 h to avoid depletion of carbon sources in the culture medium. Samples were taken periodically, and the total cell lysate was analyzed by SDS-PAGE.
Solubilization and purification. Induced cells from the fermenter were centrifuged at 16;000 g for 20 min at 4 C. The inclusion body was isolated and purified from the cell pellet using BugBuster reagent and Benzonase nuclease (Novagen, Madison, WI). The cell pellet was suspended in a 5-times volume of BugBuster reagent (v/w) and 0.25% (v/v) of Benzonase nuclease and mixed by vortex, followed by incubation for 20 min at room temperature. The solution was centrifuged at 16;000 g for 20 min at 4 C, and then the supernatant was removed from the precipitate. The inclusion bodies thus obtained were washed twice with 20 mM Tris buffer, pH 8.0, containing 5 mM EDTA and 2% deoxycholate. They were further washed twice with distilled water to remove contaminating salt and detergent, and centrifuged at 16;000 g for 15 min at 4 C. The purified inclusion bodies containing r-hGH was dissolved in 100 mM Tris buffer, pH 8.0 or 12.5, in the presence of 0, 0.5, 1, 2, 4, 8 M urea or 0, 0.5, 1, 2, 4, 6 M GnHCl for 1 h at 4 C at a concentration of 3 mg/ml r-hGH, quantified as described below. The solution was centrifuged at 16;000 g for 20 min at 4 C. Solubilized proteins in the supernatant of 100 mM Tris buffer, pH 12.5, with 2 M GnHCl were taken and refolded by 32-fold dilution with 100 mM Tris buffer pH 8.0. The refolded r-hGH solution was further diluted 10-fold in distilled water, and applied to DEAE Sepharose Fast Flow chromatography (GE Healthcare, Buckinghamshire, UK) equilibrated with 20 mM Tris buffer pH 8.0. The column was washed with the same buffer and eluted with 25, 50, 100, 150, and 1,000 mM NaCl in the same buffer. After purity was checked by SDS-PAGE following SYPRO Ruby staining (Bio-Rad Laboratories, Hercules, CA), the fraction showing the highest purity was stored at 4 C until use.
Analytical methods. The optical density of each culture sample was measured at 600 nm with an Ultrospec 100 pro spectrophotometer (GE Healthcare). The glucose concentration was estimated with enzymatic test kit Pretest 4bII (Wako, Osaka, Japan). For quantification of r-hGH, the aliquot was subjected to 12.5% SDS-PAGE, followed by Coomassie brilliant blue (CBB) staining. The resulting protein bands were scanned, and then the images acquired were analyzed with Image J software (NIH, Boston, MA). The amount of r-hGH in the samples was determined using the calibration curves of the hGH standard (Wako), which were co-electrophoresed with samples.
Bioactivity assay. The biological activity of r-hGH was confirmed using the hGH-dependent BaF/GM cell line, which is a mouse proB cell line Ba/F3 cells expressing the chimera receptor, consisting of the extracellular region of the hGH receptor and the intracytoplasmic region of the human thrombopoietin receptor, c-Mpl. The BaF/GM cells were maintained in RPMI1640 medium supplemented with 10% fetal bovine serum (FBS), 400 mg/ml G418, and 100 ng/ml hGH under atmospheric conditions with 5% CO 2 at 37 C. BaF/GM cells arrested at the G 0 /G 1 phases were prepared by cultivation in RPMI1640 supplemented with 10% horse serum (HS) and 100 mg/ml G418. r-hGH or the hGH standard was added to the culture medium at various concentrations (0.009-60 ng/ml). Cell proliferation was evaluated using CellTiter96 Aqueous NonRadioactive Cell Proliferation Assay reagent (Promega, Madison, WI) after incubation for 22 h.
Results and Discussion
High-cell-density culture and heat-induced production of r-hGH Expression of r-hGH was confirmed in a small-scale culture of E. coli BL21 harboring pRL-hGH using LB medium. A high-expressor clone was used in the subsequent fermentation experiments. r-hGH was overproduced by pH-stat fed-batch culture in synthetic medium TK-25 supplemented with yeast extract, which was found to be effective in improving plasmid stability. 16) Cultures at an OD 600 of 50 were induced by changing the temperature from 32 C to 42 C, and were grown for another 5 h. Cultivation was terminated at an OD 600 of 77 (Fig. 1A) . Production of r-hGH reached to a plateau after 3 h of heat induction (Figs. 1A   and 2) . From a number of fermentation experiments, the optimal duration of heat-induction was 3-5 h. The level of r-hGH expression was approximately 3.4 g/l, and it constituted about 18% of total cellular protein. On the other hand, it has been reported that 1.6 g/l of r-hGH was expressed at a cell OD 600 of 60 using a combination of phage T5 promoter and the original hGH gene, 14) and 2.7 g/l at an OD 550 of 200 using that of the T7 promoter under the control of the P L promoter and the original hGH gene sequence.
18) It is possible that enhancement of r-hGH productivity in E. coli cells harboring pRL-hGH is facilitated by the use of the synthesized hGH gene, which is optimized for the E. coli expression system. The initial glucose in the medium was consumed completely at 6.5 h of culture time, starting from the time glucose was fed to the culture medium at 10-30 g/l at variable intervals to avoid complete consumption of the carbon source (Fig. 1B) . In batch culture without glucose feeding, the final cell density and production level were one half and one quarter respectively (data not shown). Recombinant E. coli cells were cultured at 32 C without induction, and no r-hGH was expressed at this temperature (Fig. 2, lane 1) , which indicates that the expression of r-hGH was tightly regulated by the P RL promoter/cI857 repressor expression system and that there was no leaky expression. The temperature-sensitive cI857 repressor makes possible the control of gene expression by changing the growth temperature instead of by induction by a chemical inducer such as IPTG, which is undesirable in the large-scale production of human therapeutic protein due to its toxicity and cost. A temperature shift from 30 C to 42 C caused induction C to 42 C. Samples were taken at intervals to monitor cell growth and r-hGH concentration. At the end of fermentation (at an OD 600 of 77), the cells were harvested and processed for isolation of inclusion bodies. B, Glucose consumption during fermentation. Glucose was fed as a carbon source before it was consumed completely in the culture medium. The glucose concentration was measured as described in ''Materials and Methods.'' Glucose feeding was started after 6.5 h. Symbols: , cell growth (OD 600 ); , r-hGH; , glucose concentration. of heat-shock protein synthesis and increased the degradation of heterologous proteins by E. coli proteases. 19, 20) As shown in Fig. 2 , there were no detectable differences in band patterns of the total cellular protein as between pre-and post-induction on SDS-PAGE, suggesting that high temperature does not induce the expression of the host cell proteins that become problematic in our expression system. Furthermore, no degradation of r-hGH was observed on SDS-PAGE or Western blot analysis (data not shown), possibly due to prevention of proteolytic attack by rapid formation of the r-hGH inclusion body and the use of the BL21 strain as a host cell deficient in lon and ompT proteases. Productivity might be improved by changing the induction temperature from 42 C to 37 C at an optimal point, because heat-induction by 42 C is stressful on E. coli cell growth and protein production.
Solubilization of r-hGH
It has been reported that r-GH inclusion bodies of different species expressed in E. coli are solubilized at alkaline pH. [21] [22] [23] It has also been found that the solubilization of r-hGH inclusion bodies at alkaline pH in the presence of 2 M urea solution was more efficient than at alkaline pH only. This method resulted in about 94% of solubility, and the overall yield of the purified r-hGH was about 50% of the initial inclusion body proteins. 14) Hence we first tried to solubilize the r-hGH inclusion bodies at alkaline pH in the presence of 2 M urea, but efficient solubilization of r-hGH was not achieved. Hence the purified r-hGH inclusion bodies were solubilized at different concentrations of urea and GnHCl at pH 8.0 and 12.5, and the percentage solubilization of r-hGH was estimated by densitometric scanning of the 22-kDa bands on the stained gels. Solubilization of the r-hGH from inclusion bodies was observed at pH 8.0 and 12.5, with relative solubility of 0% and about 40% respectively. As shown in Fig. 3A , the addition of less than 4 M of urea was not effective at all at pH 8.0 or 12.5. At pH 12.5 in the presence of 8 M urea, approximately 70% of the inclusion bodies were solubilized. On the other hand, the solubility of r-hGH inclusion bodies was greatly improved by adding 2 M GnHCl at pH 12.5, resulting in about 95% solubility (Fig. 3B) . In the presence of 4 and 6 M of GnHCl, solubility was high in spite of the pH conditions, suggesting that the native-like secondary structure of rhGH might be broken under these conditions as by the early methods using high concentrations of chaotropic agents. In order to solubilize as mildly as possible, conditions with a lower concentration of chaotropic agent was selected. Three mg/ml of r-hGH inclusion bodies was solubilized in 100 mM Tris buffer at pH 12.5 with the addition of 2 M GnHCl, and the solution was used in the next renaturation step.
Our results, however, did not agree with an earlier report, 14) in which about 94% solubility at alkaline pH in the presence of 2 M urea solution was achieved. But there was an apparent difference in the purity of the inclusion body; that is, the inclusion body purified using a French press was obviously of high purity as compared with that using the chemical lysis reagent. It is possible that the solubility of inclusion bodies under mild conditions is highly dependent on purity. It is known that the formation of inclusion bodies caused by aggregation through hydrophobic and ionic interactions is dependent on the rate of biosynthesis of the target protein, which is affected by culture conditions, such as temperature during induction. Across production systems, the purity and degree of aggregation of inclusion bodies can vary by host cell, target protein, and culture conditions. The solubilization method using 2 M GnHCl provides an additional efficient means when solubility at alkaline pH with and without urea is ineffective.
Purification and bioactivity of r-hGH Solubilized r-hGH was refolded by 32-fold dilution with 100 mM Tris buffer, pH 8.0. Aggregation was observed during dilution, but no r-hGH was included in it. About 90% of the solubilized protein was refolded by the above refolding procedure. The effect of a supple- C for 1 h, the sample solutions were centrifuged at 16;000 g for 20 min at 4 C. Then the amount of r-hGH in the supernatant and precipitate was measured, as described in ''Materials and Methods.'' Average results from two experiments are shown. ment of 0.5 M L-arginine was evaluated in a parallel set of experiments, but no enhancement of refolding efficiency was observed. Moreover, neither reducing nor oxidizing agents were required for the refolding process. The resulting r-hGH was bioactive, as described below, suggesting that the intramolecular disulfide bonds of r-hGH were formed correctly. During the solubilization, refolding, and purification processes, air might work as a mild oxidizing agent. The refolded r-hGH was purified by one step of anion-exchange chromatography and the biological activity was measured. The solution of the refolded r-hGH was applied to a DEAE Sepharose Fast Flow column, and the purity of each fraction was checked by SDS-PAGE, followed by SYPRO Ruby staining. The fraction with the highest purity (greater than 90%) was obtained in the fraction of 100 mM NaCl (Fig. 4, lane 5) . The recovery of r-hGH eluted in this fraction corresponded to 40%. Almost the same amount of r-hGH was eluted in the fraction of 150 mM NaCl, but this fraction included much higher impurities than 100 mM NaCl (data not shown).
The biological activity of r-hGH was evaluated by measuring growth-promoting activity in the hGH-dependent BaF/GM cell line, which was arrested at the G 0 /G 1 phases by FBS depletion, based on MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] cell growth assay. The proliferation of BaF/GM cells under various concentrations of the r-hGH and hGH standards was measured. As shown in Fig. 5 , the cell growth promoting activity of the r-hGH was found to be comparable to that of the hGH standard, indicating that the refolded and purified r-hGH has a biologically active conformation.
High-level production combined with efficient solubilization of the inclusion body in the presence of 2 M GnHCl might be applied for cost-effective production of r-hGH in E. coli. Induced cells were harvested after 5 h of induction, and r-hGH was subsequently purified. Samples at each step were applied to 12.5% gel under reducing conditions and stained with Coomassie Brilliant Blue G-250 (lanes 1-4) and SYPRO Ruby (lanes 5, 6). Lane M, molecular weight marker; lane 1, induced cell lysate; lane 2, purified inclusion body; lane 3, r-hGH solubilized at pH 12.5 with 2 M GnHCl; lane 4, r-hGH refolded by the dilution method; lane 5, r-hGH purified by DEAE anion exchange chromatography; lane 6, pure hGH standard. Arrow indicates r-hGH.
